Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Henry Schein Buying AUV Veterinary Services

By Pharmaceutical Processing | April 11, 2012

MELVILLE, N.Y. (AP) — Henry Schein Inc. is buying veterinary distribution business AUV Veterinary Services B.V. from the privately held AUV Group, in part to gain access to the Dutch and Belgian animal health markets.

Financial terms were not disclosed.

AUV Veterinary Services, which had 2011 sales of $270.4 million, serves animal health practitioners in the Netherlands and Belgium. The company also includes AUV Advies, a consulting business serving veterinary practices, and AUV Academie, an education offering for veterinarians and their staff.

AUV Group, which is based in Cuijk, Netherlands, includes a distribution business and a pharmaceutical business. It also includes a majority stake in a pet insurance business and the holding company. The acquisition involves only AUV Group’s distribution and related businesses, which serve more than 2,000 large and small animal veterinarians.

Henry Schein provides health care products and services to dental, medical and veterinary practitioners. In February its fourth-quarter profit rose 13 percent, with acquisitions helping its international sales.

“AUV will provide Henry Schein entry into the Dutch and Belgian animal health markets as the category leader. This important addition will further our Pan-European strategy of providing animal health practitioners across the continent with the products and services needed to operate more efficient practices and provide high quality care,” Henry Schein CEO Stanley Bergman said in a statement Wednesday.

The transaction is expected to slightly reduce Henry Schein’s 2012 earnings per share and add to its earnings per share after that. The buyout is expected to bring revenue for the Melville, N.Y., company’s animal health business to more than $2 billion annually.

The acquisition is expected to close later in the quarter.

 

 

Related Articles Read More >

These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE